Terrie Curran

2020

In 2020, Terrie Curran earned a total compensation of $4.6M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 34% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$356,875
Option Awards$3,285,608
Salary$498,940
Stock Awards$483,000
Other$10,031
Total$4,634,454

Curran received $3.3M in option awards, accounting for 71% of the total pay in 2020.

Curran also received $356.9K in non-equity incentive plan, $498.9K in salary, $483K in stock awards and $10K in other compensation.

Rankings

In 2020, Terrie Curran's compensation ranked 2,416th out of 13,090 executives tracked by ExecPay. In other words, Curran earned more than 81.5% of executives.

ClassificationRankingPercentile
All
2,416
out of 13,090
82nd
Division
Manufacturing
923
out of 5,621
84th
Major group
Chemicals And Allied Products
327
out of 2,254
86th
Industry group
Drugs
278
out of 1,954
86th
Industry
Pharmaceutical Preparations
200
out of 1,459
86th
Source: SEC filing on April 6, 2021.

Curran's colleagues

We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2020.

2020

Azmi Nabulsi

Phathom Pharmaceuticals

Chief Operating Officer

2020

Todd Branning

Phathom Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like